Question 1

What is Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent?

Accepted Answer

Intellia Therapeutics (NTLA) reported comprehensive income (loss), net of tax, attributable to parent of -$97.5M in Q1 2026.

Question 2

How has Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?

Accepted Answer

Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent increased by 14.4% year-over-year, from -$113.88M to -$97.5M.

Question 3

What is the long-term trend for Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent?

Accepted Answer

Over 4 years (2021 to 2025), Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a 11.1% compound annual growth rate (CAGR), from -$270.53M to -$412.27M.

Question 4

What does comprehensive income (loss), net of tax, attributable to parent mean?

Accepted Answer

This metric represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as foreign currency translation adjustments and unrealized gains or losses on financial instruments. It provides a comprehensive view of the company's total financial performance and changes in net worth beyond standard operating results. Investors use this to understand the broader economic impact on the company's balance sheet and total equity position.

Intellia Therapeutics NTLA Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

Ask your AI about Intellia Therapeutics's comprehensive income (loss), net of tax, attributable to parent.

Questions, answered.